Skip to content 
Veradermics, Incorporated operates as a biopharmaceutical company focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children. The company's products include VDPHL01, an oral, non-hormonal treatment for men and women with PHL for chronic hair loss therapy. Additionally, it engages in the development of VDMN, a dissolvable microarray patch technology for immunotherapy of common warts; VDAA for the treatment of alopecia areata; and VDMC for the treatment of molluscum contagiosum. Its products are used for the treatment of androgenetic alopecia, common warts, molluscum contagiosum, alopecia areata, and atopic dermatitis. The company serves healthcare providers and clinicians treating dermatologic and aesthetic conditions in both adult and pediatric populations, as well as the broader medical and clinical research community involved in dermatology. Veradermics, Incorporated was founded in 2019 and is based in New Haven, Connecticut. more
| Dec '23 | Dec '24 | |||||
|---|---|---|---|---|---|---|
| Total Revenue | - | - | [{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}] | |||
| Cost of Revenue | - | - | [{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}] | |||
| Gross Profit | - | - | [{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}] | |||
| Gross Margin | - | - | [{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}] | |||
| Operating Expenses | 17.32M | 26.78M | [{"date":"2023-12-31","value":64.69,"profit":true},{"date":"2024-12-31","value":100,"profit":true}] | |||
| Operating Income | (17.32M) | (26.78M) | [{"date":"2023-12-31","value":-1732400000,"profit":false},{"date":"2024-12-31","value":-2677800000,"profit":false}] | |||
| Total Non-Operating Income/Expense | 1.67M | 186.00K | [{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":11.15,"profit":true}] | |||
| Pre-Tax Income | (16.49M) | (26.49M) | [{"date":"2023-12-31","value":-1648999900,"profit":false},{"date":"2024-12-31","value":-2648800000,"profit":false}] | |||
| Income Taxes | - | - | [{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}] | |||
| Income After Taxes | - | - | [{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}] | |||
| Income From Continuous Operations | (16.49M) | (26.49M) | [{"date":"2023-12-31","value":-1649000000,"profit":false},{"date":"2024-12-31","value":-2648800000,"profit":false}] | |||
| Income From Discontinued Operations | - | - | [{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}] | |||
| Net Income | (16.49M) | (26.49M) | [{"date":"2023-12-31","value":-1648999900,"profit":false},{"date":"2024-12-31","value":-2648800000,"profit":false}] | |||
| EPS (Diluted) | - | - | [{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}] | |||
These ratios help you determine the liquidity of the company. Higher is better.
| MANE | |
|---|---|
| Cash Ratio | 2.66 |
| Current Ratio | 3.29 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| MANE | |
|---|---|
| ROA (LTM) | 0.00% |
| ROE (LTM) | 0.00% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| MANE | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 6.11 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | -5.11 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| MANE | |
|---|---|
| Trailing PE | NM |
| Forward PE | NM |
| P/S (TTM) | 0.00 |
| P/B | 0.00 |
| EV/R | 0.00 |
| EV/Ebitda | NM |
Veradermics, Incorporated (MANE) share price today is $50.08
Yes, Indians can buy shares of Veradermics, Incorporated (MANE) on Vested. To buy
Yes, you can purchase fractional shares of Veradermics, Incorporated (MANE) via the Vested app. You can start investing in Veradermics, Incorporated (MANE) with a minimum investment of $1.
You can invest in shares of Veradermics, Incorporated (MANE) via Vested in three simple steps:
The 52-week high price of Veradermics, Incorporated (MANE) is $47.79. The 52-week low price of Veradermics, Incorporated (MANE) is $32.
The price-to-earnings (P/E) ratio of Veradermics, Incorporated (MANE) is
The price-to-book (P/B) ratio of Veradermics, Incorporated (MANE) is 0.00
The dividend yield of Veradermics, Incorporated (MANE) is 0.00%
The market capitalization of Veradermics, Incorporated (MANE) is $1.66B
The stock symbol (or ticker) of Veradermics, Incorporated is MANE
Consider the share price of Veradermics, Incorporated as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Veradermics, Incorporated has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Veradermics, Incorporated shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Veradermics, Incorporated stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Veradermics, Incorporated and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Veradermics, Incorporated stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
